Imunon, Inc. Proceeds from Issuance of Private Placement
Imunon, Inc. (IMNN) reported Proceeds from Issuance of Private Placement of $1.00 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2024-03-28
- Imunon, Inc. proceeds from issuance of private placement for the quarter ending 2023-03-31 was $1.00M, a 0.00% change year-over-year.
- Imunon, Inc. proceeds from issuance of private placement for the quarter ending 2022-12-31 was $0.00.
- Imunon, Inc. proceeds from issuance of private placement for the quarter ending 2022-09-30 was $0.00.
- Imunon, Inc. proceeds from issuance of private placement for the quarter ending 2022-06-30 was $0.00.
- Imunon, Inc. proceeds from issuance of private placement for fiscal 2023 was $1.00M, a 0.00% change from fiscal 2022.
- Imunon, Inc. proceeds from issuance of private placement for fiscal 2022 was $1.00M.
| Period end | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|---|
| 2023-12-31 | $1.00M 10-K · filed 2024-03-28 | |||
| 2023-03-31 | $1.00M 10-Q · filed 2023-05-11 | $1.00M derived: sum of 2 quarters · filed 2023-05-11 | $1.00M derived: sum of 3 quarters · filed 2023-05-11 | $1.00M derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $0.00 derived: sum of 2 quarters · filed 2023-03-30 | $0.00 derived: sum of 3 quarters · filed 2023-03-30 | $1.00M 10-K · filed 2023-03-30 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $1.00M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $1.00M 10-Q · filed 2022-08-15 | ||
| 2022-03-31 | $1.00M 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |